Search results
Results from the WOW.Com Content Network
New Covid boosters from Pfizer and Moderna designed to target the XBB.1.5 subvariant have been approved by the US Food and Drug Administration and are expected to be made available later this week.
New Covid boosters approved as CDC set to decide who should receive them amid rising cases Monday 11 September 2023 19:38 , Graeme Massie Health officials say that the Pfizer and Moderna shots ...
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
Last year's fall booster was approved in mid-September 2023 and protected against XBB coronavirus strains, for example. But experts are predicting yet another wave to occur later in the year, as ...
Which companies have a new booster available? On Monday, the U.S. Food and Drug Administration approved new mRNA boosters from Moderna and Pfizer. Approval for another booster from Novavax is ...
On Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review of its Spikevax 2024-2025 formula, which targets the SARS-CoV-2 variant JN.1. The submission is ...
The FDA authorizes the first bivalent COVID-19 booster for ages 5-11. ... CDC approves Pfizer, Moderna's COVID-19 boosters for ages 5 and up. Anjalee Khemlani. October 12, 2022 at 10:24 AM.
The new Covid boosters appear to work against the BA.2.86 omicron subvariant, Moderna and Pfizer said Wednesday. New Covid boosters work against the highly mutated BA.2.86 variant, vaccine makers ...